394 related articles for article (PubMed ID: 31023446)
1. Inflammation, Immunity, and Oxidative Stress in Hypertension-Partners in Crime?
Barrows IR; Ramezani A; Raj DS
Adv Chronic Kidney Dis; 2019 Mar; 26(2):122-130. PubMed ID: 31023446
[TBL] [Abstract][Full Text] [Related]
2. Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?
Madhur MS; Elijovich F; Alexander MR; Pitzer A; Ishimwe J; Van Beusecum JP; Patrick DM; Smart CD; Kleyman TR; Kingery J; Peck RN; Laffer CL; Kirabo A
Circ Res; 2021 Apr; 128(7):908-933. PubMed ID: 33793336
[TBL] [Abstract][Full Text] [Related]
3. Inflammation, immunity, and hypertensive end-organ damage.
McMaster WG; Kirabo A; Madhur MS; Harrison DG
Circ Res; 2015 Mar; 116(6):1022-33. PubMed ID: 25767287
[TBL] [Abstract][Full Text] [Related]
4. TLR costimulation causes oxidative stress with unbalance of proinflammatory and anti-inflammatory cytokine production.
Lavieri R; Piccioli P; Carta S; Delfino L; Castellani P; Rubartelli A
J Immunol; 2014 Jun; 192(11):5373-81. PubMed ID: 24771848
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and hypertension: new understandings and potential therapeutic targets.
De Miguel C; Rudemiller NP; Abais JM; Mattson DL
Curr Hypertens Rep; 2015 Jan; 17(1):507. PubMed ID: 25432899
[TBL] [Abstract][Full Text] [Related]
6. Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction.
Wenzel P; Knorr M; Kossmann S; Stratmann J; Hausding M; Schuhmacher S; Karbach SH; Schwenk M; Yogev N; Schulz E; Oelze M; Grabbe S; Jonuleit H; Becker C; Daiber A; Waisman A; Münzel T
Circulation; 2011 Sep; 124(12):1370-81. PubMed ID: 21875910
[TBL] [Abstract][Full Text] [Related]
7. Innate immunity in hypertension.
Mian MO; Paradis P; Schiffrin EL
Curr Hypertens Rep; 2014 Feb; 16(2):413. PubMed ID: 24407446
[TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction and hypertension in aging.
Higashi Y; Kihara Y; Noma K
Hypertens Res; 2012 Nov; 35(11):1039-47. PubMed ID: 22972557
[TBL] [Abstract][Full Text] [Related]
9. Paying the Toll for Inflammation.
McCarthy CG; Goulopoulou S; Webb RC
Hypertension; 2019 Mar; 73(3):514-521. PubMed ID: 30661480
[No Abstract] [Full Text] [Related]
10. Novel therapeutic approaches in limiting oxidative stress and inflammation.
Spychalowicz A; Wilk G; Śliwa T; Ludew D; Guzik TJ
Curr Pharm Biotechnol; 2012 Oct; 13(13):2456-66. PubMed ID: 22280420
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease.
Karbach S; Croxford AL; Oelze M; Schüler R; Minwegen D; Wegner J; Koukes L; Yogev N; Nikolaev A; Reißig S; Ullmann A; Knorr M; Waldner M; Neurath MF; Li H; Wu Z; Brochhausen C; Scheller J; Rose-John S; Piotrowski C; Bechmann I; Radsak M; Wild P; Daiber A; von Stebut E; Wenzel P; Waisman A; Münzel T
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2658-68. PubMed ID: 25341795
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.
Förstermann U
Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):338-49. PubMed ID: 18461048
[TBL] [Abstract][Full Text] [Related]
13. Toll-Like Receptors in the Pathogenesis of Essential Hypertension. A Forthcoming Immune-Driven Theory in Full Effect.
Lazaridis A; Gavriilaki E; Douma S; Gkaliagkousi E
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810594
[TBL] [Abstract][Full Text] [Related]
14. Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states.
Furman D; Chang J; Lartigue L; Bolen CR; Haddad F; Gaudilliere B; Ganio EA; Fragiadakis GK; Spitzer MH; Douchet I; Daburon S; Moreau JF; Nolan GP; Blanco P; Déchanet-Merville J; Dekker CL; Jojic V; Kuo CJ; Davis MM; Faustin B
Nat Med; 2017 Feb; 23(2):174-184. PubMed ID: 28092664
[TBL] [Abstract][Full Text] [Related]
15. Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus.
Kampoli AM; Tousoulis D; Briasoulis A; Latsios G; Papageorgiou N; Stefanadis C
Curr Pharm Des; 2011 Dec; 17(37):4147-58. PubMed ID: 22204375
[TBL] [Abstract][Full Text] [Related]
16. Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension.
Watson T; Goon PK; Lip GY
Antioxid Redox Signal; 2008 Jun; 10(6):1079-88. PubMed ID: 18315493
[TBL] [Abstract][Full Text] [Related]
17. Role of Inflammation and Immunity in Hypertension: Recent Epidemiological, Laboratory, and Clinical Evidence.
Caillon A; Schiffrin EL
Curr Hypertens Rep; 2016 Mar; 18(3):21. PubMed ID: 26846785
[TBL] [Abstract][Full Text] [Related]
18. The role of statins in endothelial dysfunction in hypertension.
Sarkar K; Sinha AK; Mehta JL
Curr Opin Cardiol; 2006 Jul; 21(4):316-21. PubMed ID: 16755200
[TBL] [Abstract][Full Text] [Related]
19. The role of chemokines in hypertension.
Martynowicz H; Janus A; Nowacki D; Mazur G
Adv Clin Exp Med; 2014; 23(3):319-25. PubMed ID: 24979502
[TBL] [Abstract][Full Text] [Related]
20. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
Wassmann S; Laufs U; Bäumer AT; Müller K; Ahlbory K; Linz W; Itter G; Rösen R; Böhm M; Nickenig G
Hypertension; 2001 Jun; 37(6):1450-7. PubMed ID: 11408394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
